Company Filing History:
2 out of 10 
3 out of 832,718 Years Active: 2013-2015
Title: Oumi Nakajima: Innovator in Anticancer Peptide Development
Introduction
Oumi Nakajima is a prominent inventor based in Kyoto, Japan. She has made significant contributions to the field of biomedical research, particularly in the development of innovative anticancer agents. With a total of 3 patents to her name, her work focuses on creating targeted therapies that minimize side effects while maximizing efficacy.
Latest Patents
One of her latest patents is for selective anticancer chimeric peptides that bind to the transferrin receptor. This invention aims to provide a substance usable as an anticancer agent or drug delivery system (DDS) that possesses intracellular stability. It is designed to evade side effects associated with normal cells and achieve instantaneous effects. The novel chimeric peptide targets cancer cells that overexpress EGFR by utilizing a binding peptide sequence and a lytic peptide sequence. This innovative approach effectively addresses the challenges faced in cancer treatment.
Another significant patent involves selective anticancer chimeric peptides that bind to the neuropilin receptor. Similar to her previous invention, this patent also aims to create a substance that can serve as an anticancer agent or DDS with intracellular stability. The chimeric peptide developed in this case targets cancer cells overexpressing EGFR, employing a binding peptide and a cytotoxic peptide to achieve its objectives.
Career Highlights
Oumi Nakajima has worked with various organizations throughout her career, including Stella Pharma Corporation. Her work has been instrumental in advancing the field of cancer therapeutics, and her patents reflect her commitment to improving patient outcomes.
Collaborations
Throughout her career, Nakajima has collaborated with notable colleagues such as Koji Kawakami and Masayuki Kohno. These partnerships have contributed to her innovative research and the successful development of her patented technologies.
Conclusion
Oumi Nakajima is a trailblazer in the field of anticancer research, with a focus on developing targeted therapies that enhance treatment efficacy while reducing side effects. Her contributions through her patents are paving the way for advancements in cancer treatment.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.